Use of a multidisciplinary continuous-quality-improvement process to investigate succinylcholine treatment failures.
Skledar
S
S
University of Pittsburgh Medical Center Health System, Drug Use and Disease State Management Program, USA. skledarsj@msx.upmc.edu
Silfies
T
T
Gross
P
P
Ryan
M
M
D002626:Chemistry, Pharmaceutical; D004341:Drug Evaluation; D019538:Health Care Surveys / Q000379:methods; D006801:Humans; D009467:Neuromuscular Depolarizing Agents / Q000008:administration & dosage*; D009719:Nurse Anesthetists; D010595:Pharmacists; D011785:Quality Assurance, Health Care / Q000379:methods*; D013390:Succinylcholine / Q000008:administration & dosage*; D017749:Total Quality Management; D017211:Treatment Failure
D009467:Neuromuscular Depolarizing Agents; D013390:Succinylcholine